-
421
Reimagining Global Health: Accelerating Change for a Sustainable Future
Published 2025-01-01Get full text
Article -
422
COVID-19 and pediatric out-of-hospital cardiac arrest using U.S. registry database
Published 2025-03-01Get full text
Article -
423
-
424
Extreme Scale Height Variations and Nozzle Shocks in Warped Disks
Published 2025-01-01Get full text
Article -
425
-
426
The Determinants of Sexual Intercourse Before Age 16 Years Among Rural Jamaican Adolescents
Published 2007-01-01Get full text
Article -
427
-
428
Effects of Switching to Netarsudil/Latanoprost Fixed Dose Combination from Various Latanoprost Regimens: The Phase 4 MORE Study
Published 2025-01-01“…Jason Bacharach,1 Ehsan Sadri,2 Gagan Sawhney,3 Casey Kopczynski,4 Mohinder M Merchea4 1North Bay Eye Associates, Inc, Petaluma, CA, USA; 2Visionary Eye Institute, Newport Beach, CA, USA; 3Georgia Eye Partners, Atlanta, GA, USA; 4Alcon, Inc, Fort Worth, TX, USACorrespondence: Jason Bacharach, North Bay Eye Associates, Inc, 104 Lynch Creek Way, Suite 15, Petaluma, CA, USA, Tel +1(707) 762-3573, Fax +1 (707) 762-6873, Email jbacharach@northbayeye.comPurpose: To determine the effect on intraocular pressure (IOP) of switching to a once-daily netarsudil/latanoprost fixed dose combination (FDC) from various topical treatment regimens including latanoprost monotherapy or latanoprost combined with other IOP-lowering agents for the treatment of open-angle glaucoma or ocular hypertension.Methods: A total of 136 participants enrolled. …”
Get full text
Article -
429
-
430
Observational research in epidemic settings: a roadmap to reform
Published 2025-02-01Get full text
Article -
431
-
432
-
433
-
434
-
435
-
436
Histological staining of tick bite skin biopsies for spirochetes and Powassan virus RNA
Published 2025-02-01Get full text
Article -
437
-
438
-
439
-
440